| Drug Name |
Lomitapide |
| Drug ID |
BADD_D01311 |
| Description |
Lomitapide is a microsomal triglyceride transfer protein (MTP) inhibitor used in homozygous familial hypercholesterolemia (HoFH) patients. It is marketed under the name Juxtapid (R). |
| Indications and Usage |
Used in homozygous familial hypercholesterolemia (HoFH) patients to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B), and non-high-density lipoprotein cholesterol (non-HDL-C). |
| Marketing Status |
approved; investigational |
| ATC Code |
C10AX12 |
| DrugBank ID |
DB08827
|
| KEGG ID |
D09637
|
| MeSH ID |
C473731
|
| PubChem ID |
9853053
|
| TTD Drug ID |
D0H8VY
|
| NDC Product Code |
Not Available |
| UNII |
82KUB0583F
|
| Synonyms |
BMS201038 | BMS-201038 | BMS 201038 | lomitapide | Juxtapid | AEGR 733 | AEGR733 | AEGR-733 |
